Sputnik疫苗的疗效达到95%，将比美国疫苗更便宜

俄罗斯的Sputnik V Covid-19疫苗，报告了95%以上的疗效，而且价格会将比辉瑞和Moderna公司的疫苗更便宜。Sputnik V由Gamaleya研究所和RDIF（俄罗斯直接投资基金）开发。在全球市场上，两剂疫苗的价格将低于20美元/人，首批国际交付将于2021年1月进行，并可能在2月前在这里上市。

Russia’s Sputnik V Covid-19 vaccine, that reported an efficacy of over 95%, will be twice as cheap as those by Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya Institute and RDIF (Russian Direct Investment Fund), will be priced under $20 per person for the two doses in global markets, and may be available here by February. The first international deliveries of the Russian Sputnik V vaccine will be made in January 2021 based on the existing partnerships with foreign manufacturers, the statement adds.  source

指尖新闻：高信噪比，一目了然

新冠疫情追踪

Whereas the initial report rested on a mere 20 cases of COVID-19, with no details on how they were split between vaccinated and placebo groups, the new analysis is based on 39 cases total, eight among the vaccinated group versus 31 in the much smaller placebo arm. “This is great news not just for Russia, but the world,” Kirill Dmitriev, CEO of the Russian Direct Investment Fund that is bankrolling the development of the candidate, announced at a virtual press conference this morning.

好歹这次有39个dp